Cargando…
Neuron navigator 2 is a novel mediator of rheumatoid arthritis
Autores principales: | Wang, Ran, Li, Meng, Ding, Qian, Cai, Jianghong, Yu, Yue, Liu, Xinhua, Mao, Jianchun, Zhu, Yi Zhun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429683/ https://www.ncbi.nlm.nih.gov/pubmed/34321621 http://dx.doi.org/10.1038/s41423-021-00696-7 |
Ejemplares similares
-
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
por: Ding, Qian, et al.
Publicado: (2023) -
STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway
por: Wang, Ran, et al.
Publicado: (2022) -
Flare of rheumatoid arthritis after COVID-19 vaccination
por: Terracina, Katherine A, et al.
Publicado: (2021) -
Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
por: Rubbert-Roth, Andrea, et al.
Publicado: (2021) -
NAV2 positively modulates inflammatory response of fibroblast‐like synoviocytes through activating Wnt/β‐catenin signaling pathway in rheumatoid arthritis
por: Wang, Ran, et al.
Publicado: (2021)